Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT)

被引：0
|
作者：
Lorch, A.
Rick, O.
Hartmann, J. T.
Metzner, B.
Glasmacher, A.
Berdel, W.
Schirren, R.
Bokemeyer, C.
Beyer, J.
机构：
[1] Univ Klinikum Giessen & Marburg, Marburg, Germany
[2] Klin Reinhardshohe, Bad Wildungen, Germany
[3] Univ Klinikum Tuebingen, Tubingen, Germany
[4] Klinikum Oldenburg, Oldenburg, Germany
[5] Univ Klinikum Bonn, Bonn, Germany
[6] Univ Klinikum Muenster, Munster, Germany
[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[8] Urban Krankenhaus Berlin, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5086
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
    Beyer, J
    Kramar, A
    Mandanas, R
    Linkesch, W
    Greinix, A
    Droz, JP
    Pico, JL
    Diehl, A
    Bokemeyer, C
    Schmoll, HJ
    Nichols, CR
    Einhorn, LH
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1998, 22 : S10 - S10
  • [2] Significance of high-dose chemotherapy (HDCT) for male germ cell tumors
    Lorch, A.
    Beyer, J.
    Bokemeyer, C.
    ONKOLOGE, 2013, 19 (07): : 568 - 572
  • [3] Has toxicity in young patients with Germ Cell Tumor (GCT) treated with High-Dose Chemotherapy (HDCT) any impact on weight?
    Giannotti, F
    Civinelli, MC
    Martelli, S
    Amati, P
    Peccenini, R
    Zambianchi, H
    Papiani, G
    De Giorgi, L
    Cavallaro, M
    Rosti, G
    Marangolo, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S389 - S389
  • [4] Management of progressive brain metastases in patients (pts) with relapsed germ-cell tumor (GCT) treated with salvage high-dose chemotherapy (HDCT).
    King, Jennifer
    Abonour, Rafat
    Hassoun, Rebecca
    Althouse, Sandra K.
    Salous, Tareq
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts).
    Feldman, Darren Richard
    Voss, Martin Henner
    Jia, Xiaoyu
    Van Alstine, Lindsay Joy
    Patil, Sujata
    Fischer, Patricia
    Sheinfeld, Joel
    Bosl, George J.
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] INFECTIONS IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY FOR GERM-CELL TUMORS
    DAUGAARD, G
    NIELSEN, H
    BRUUN, B
    HANSEN, F
    GEERTSEN, P
    SCHONHEYDER, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) : 2220 - 2222
  • [7] High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
    Beyer, J.
    Hackenthal, M.
    Lorch, A.
    Neubauer, A.
    Dieing, A.
    Rick, O.
    Hartmann, J. T.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Multicenter analysis of high-dose chemotherapy (HDCT) regimens for recurrent germ cell tumors (GCTs).
    Zugman, Miguel
    Shodiya, Michael Olufemi
    Maldonado, Edward
    Othman, Tamer
    Ebrahimi, Hedyeh
    Barragan-Carrillo, Regina
    Li, Xiaochen
    Rock, Adam
    Tripathi, Abhishek
    Pal, Sumanta Kumar
    Dorff, Tanya B.
    Zhumkhawala, Ali
    Hoeg, Rasmus Tetens
    Oliai, Caspian
    Mei, Matthew Genyeh
    Chehrazi-Raffle, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [9] Impact of response to induction chemotherapy in patients with germ cell tumors (GCT) receiving salvage high-dose chemotherapy (HDCT): an EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study
    Necchi, A.
    Miceli, R.
    Bregni, M.
    Berger, L. A.
    Oechsle, K.
    Schumacher, K.
    Bourhis, J. H.
    Laszlo, D.
    Flechon, A.
    Arpaci, F.
    Secondino, S.
    Raggi, D.
    Dreger, P.
    Krueger, W.
    Ringhoffer, M.
    Unal, A.
    Nagler, A.
    Campos
    Wahlin
    Donnini, I.
    Badoglio, M.
    Martino, M.
    Pedrazzoli, P.
    Lanza, F.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S53 - S53
  • [10] Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study
    Necchi, Andrea
    Badoglio, Manuela
    Miceli, Rosalba
    Bourhis, Jean-Henri
    Laszlo, Daniele
    Nicolas-Virelizter, Emmanuelle
    Wuchter, Patrick
    Dreger, Peter
    Kruger, William Hermann
    Unal, Ali
    Campos, Antonio
    Montoro, Juan
    Raggi, Daniele
    Giannatempo, Patrizia
    Gianni, Alessandro M.
    Pedrazzoli, Paolo
    Lanza, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345